Notice of Intent to Sole Source to Bio-Rad for a Bio-Plex 200 System

The Centers for Disease Control and Prevention intends to award a sole source firm fixed price purchase order to Bio-Rad for a Bio-Plex 200 System, which will be used in studies to identify biomarkers associated with, and to develop, laboratory test panels for the identification of PrEP breakthrough and occult HIV infections that are not detectable by current FDA-approved HIV diagnostic assays. Bio-Rad is one of two vendors that sell bead-based multiplex array systems; however, the Bio-Rad Bio-Plex 200 is unique among the two, in that it has an FDA approved HIV antigen-antibody test available for it. Bio-Rad is the only provider for the the Bio-Plex 200 System. This contract action is for supplies or services for which the Government intends to solicit and negotiate with only one source under the authority of FAR 13.106-1(b) (SAP) and 10 U.S.C. 2304(c)(1). Interested persons may identify their interest and capability to respond to the requirement or submit proposals. This notice of intent is not a request for competitive quotations; however, all quotations/responses received within fifteen (15) days of the issuance of this notice will be considered by the government. A determination by the government not to compete this proposed contract based upon responses to this notice is solely within the discretion of the government. Information received will normally be considered solely for the purpose of determining whether to conduct a competitive procurement. Any quotation/response should be emailed to contract specialist at [email protected] by 3:00PM EDT August 22, 2023.